Preclinical Studies Of Glucocorticoid Receptor Antagonists In The Treatment Of Alcohol Dependence | 18036
Journal of Addiction Research & Therapy
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
lucocorticoid levels are markedly altered by acute and prolonged exposure to intoxicating doses of ethanol, yet the
behavioral significance of these alterations are not fully understood. Prior work has shown that ethanol withdrawal
associated cognitive deficits in mice can be reduced by acute administration of a glucocorticoid receptor (GR) antagonist
and we have also shown that chronic ethanol consumption increases the brain concentrations of corticosterone in rodents.
work has shown that corticosterone increases alcohol withdrawal neurotoxicity and calcium accumulation in
hippocampal neurons. Our current work focuses on the ability ofglucocorticoid antagonist drugs to reduce the behavioural
consequences of alcohol withdrawal. Administration of one dose of the Type 2 GR antagonist, mifepristone, immediately
after alcohol withdrawal, prevented the subsequent memory deficits in mice and significantly lowered withdrawal signs.
Repeated doses of this drug, given torats during a 4-day binge alcohol treatment, substantially reduced the acute signs of
alcohol withdrawal. We have also studied the effects of the mifepristone analogue, ORG34517 that is more selective and lacks
progesterone antagonist action. This compound significantly reduced acute withdrawal signs in rats and memory deficits in
mice when given prior to withdrawal from chronic alcohol treatment. As a whole, these findings suggest that GR may represent
therapeutic targets to be exploited in the treatment of ethanol dependence
Sharrett-Field L received her Bachelor of Science degree in Psychology from the University of Southern Indiana in 2008. She completed Master of Science degree
in Experimental Psychology with expertise in behavioral neuroscience in 2010 and a Doctor of Philosophy degree in this discipline in 2013. She has extensive
expertise in biochemical, surgical and behavioral approaches to the study of alcohol addiction and its treatment. Her publications reflect a focus on understanding
how glucocorticoid hormone receptor systems are altered by alcohol exposure, employing both in vitro and in vivo models, and how these systems may be
pharmacologically exploited in the treatment of alcohol dependence
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals